Race-neutral pulmonary function testing, now recommended by ATS and implemented at Boston Medical Center, has had a long road to acceptance.
This important study presents convincing findings on creating an exhaustive library of new enhancer-AAVs targeting astrocytes and oligodendrocytes with high potential for both basic and translational ...
Fredun Pharmaceuticals Limited (BSE - FREDUN \| 539730) is one of the leading pharmaceuticals formulation manufacturing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results